A major international trial has found that pulsed-field catheter ablation offers superior outcomes to antiarrhythmic drugs for patients with persistent atrial fibrillation. One year after treatment, ...
Treatment success with pulsed field ablation was higher at 1 year than with antiarrhythmic drug therapy for patients with persistent atrial fibrillation.
A major international trial led by the University of British Columbia found that starting treatment with catheter-based pulsed field ablation offers better rhythm control than medication for patients ...
We also report below on early data that poses a possible solution to a devastating pregnancy complication, and a potential ...
At HRS 2026, Dr. Song Zuo presented evidence that AI can detect atrial fibrillation with over 90% sensitivity, ...
Stanford's Dr. Perez shows Apple Watches detect AFib with 86% accuracy, offering accessible cardiac monitoring as 115M ...
AFNET 6 trial used large language models to extract AF burden from pacemaker data in patients with device-detected atrial fibrillation. This approach enables to evaluate the impact of AF burden on ...
Over the last weekend, Chicago played host to the 2026 edition of the Heart Rhythm Society's annual conference (HRS 2026).
Interim results highlight six-month outcomes for patients treated with the Sphere-9 catheter for sustained monomorphic ventricular tachycardia (VT)Breakthrough device designation granted for use of th ...
Superior efficacy and comparable safety was seen with DFD-29 in patients with rosacea when compared with the current first-line systemic.
There are both clinical and economic implications, as payers have been discouraging ablation in this population, one expert ...
Where (and how) you wear your health tracker can impact your data accuracy. Here's what researchers say matters most.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results